^„Human PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
^Monaghan G, Clarke DJ, Povey S, See CG, Boxer M, Burchell B (фебруар 1995). „Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13”. Genomics. 23 (2): 496—9. PMID7835904. doi:10.1006/geno.1994.1531.CS1 одржавање: Формат датума (веза)
Coffman BL, Tephly TR, Irshaid YM, et al. (1990). „Characterization and primary sequence of a human hepatic microsomal estriol UDPglucuronosyltransferase.”. Arch. Biochem. Biophys. 281 (1): 170—5. PMID2116769. doi:10.1016/0003-9861(90)90428-2.
Irshaid YM, Tephly TR (1987). „Isolation and purification of two human liver UDP-glucuronosyltransferases.”. Mol. Pharmacol. 31 (1): 27—34. PMID3100939.
Green MD, Clarke DJ, Oturu EM, et al. (1995). „Cloning and expression of a rat liver phenobarbital-inducible UDP-glucuronosyltransferase (2B12) with specificity for monoterpenoid alcohols.”. Arch. Biochem. Biophys. 322 (2): 460—8. PMID7574722. doi:10.1006/abbi.1995.1489.
Green MD, Oturu EM, Tephly TR (1995). „Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates.”. Drug Metab. Dispos. 22 (5): 799—805. PMID7835232.
Chen F, Ritter JK, Wang MG, et al. (1993). „Characterization of a cloned human dihydrotestosterone/androstanediol UDP-glucuronosyltransferase and its comparison to other steroid isoforms.”. Biochemistry. 32 (40): 10648—57. PMID8399210. doi:10.1021/bi00091a015.
Guillemette C, Lévesque E, Beaulieu M, et al. (1997). „Differential regulation of two uridine diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells.”. Endocrinology. 138 (7): 2998—3005. PMID9202245. doi:10.1210/endo.138.7.5226.
Lévesque E, Beaulieu M, Green MD, et al. (1997). „Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene.”. Pharmacogenetics. 7 (4): 317—25. PMID9295060. doi:10.1097/00008571-199708000-00007.
Tchernof A, Lévesque E, Beaulieu M, et al. (1999). „Expression of the androgen metabolizing enzyme UGT2B15 in adipose tissue and relative expression measurement using a competitive RT-PCR method.”. Clin. Endocrinol. 50 (5): 637—42. PMID10468930. S2CID43030627. doi:10.1046/j.1365-2265.1999.00709.x.
Strassburg CP, Kneip S, Topp J, et al. (2000). „Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine.”. J. Biol. Chem. 275 (46): 36164—71. PMID10748067. doi:10.1074/jbc.M002180200.
Gsur A, Preyer M, Haidinger G, et al. (2002). „A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk.”. Cancer Epidemiol. Biomarkers Prev. 11 (5): 497—8. PMID12010866.
Iida A, Saito S, Sekine A, et al. (2002). „Catalog of 86 single-nucleotide polymorphisms (SNPs) in three uridine diphosphate glycosyltransferase genes: UGT2A1, UGT2B15, and UGT8.”. J. Hum. Genet. 47 (10): 505—10. PMID12376738. doi:10.1007/s100380200075.
Court MH, Duan SX, Guillemette C, et al. (2003). „Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9.”. Drug Metab. Dispos. 30 (11): 1257—65. PMID12386133. doi:10.1124/dmd.30.11.1257.
Kanaya J, Takashima M, Koh E, Namiki M (2003). „Androgen-independent growth in LNCaP cell lines and steroid uridine diphosphate-glucuronosyltransferase expression.”. Asian J. Androl. 5 (1): 9—13. PMID12646996.
Zhang JY, Zhan J, Cook CS, et al. (2003). „Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism.”. Drug Metab. Dispos. 31 (5): 652—8. PMID12695355. S2CID23434477. doi:10.1124/dmd.31.5.652.
Tomboc M, Witchel SF (2003). „Frequencies of the D85 and Y85 variants of UGT2B15 in children and adolescent girls with hyperandrogenism.”. J. Pediatr. Endocrinol. Metab. 16 (5): 719—26. PMID12880121. S2CID32217321. doi:10.1515/jpem.2003.16.5.719.
Court MH, Hao Q, Krishnaswamy S, et al. (2005). „UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver.”. J. Pharmacol. Exp. Ther. 310 (2): 656—65. PMID15044558. S2CID5946464. doi:10.1124/jpet.104.067660.
Toide K, Umeda S, Yamazaki H, et al. (2005). „A major genotype in UDP-glucuronosyltransferase 2B15.”. Drug Metab. Pharmacokinet. 17 (2): 164—6. PMID15618667. doi:10.2133/dmpk.17.164.
Chouinard S, Pelletier G, Bélanger A, Barbier O (2005). „Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium.”. Endocr. Res. 30 (4): 717—25. PMID15666817. S2CID10971899. doi:10.1081/ERC-200044014.